This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biolamina Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Karl Anders Fredrik Lanner
Introduction
Karl Anders Fredrik Lanner is a notable inventor based in Nykvarn, Sweden. He has made significant strides in the field of stem cell research, particularly in the production of retinal pigment epithelium (RPE) cells. His work has implications for various treatments and advancements in regenerative medicine.
Latest Patents
Lanner holds a patent for "Methods for producing retinal pigment epithelium cells." This method involves providing a culture of human pluripotent stem cells that are adherent on a substrate comprising a specific laminin. The process includes exposing the stem cells to a differentiation medium for a period ranging from 15 to 50 days to obtain a population of adherent cells that include RPE cells and their progenitors. Following this, the first population is dissociated from the substrate and replated on a second substrate for further culturing. The patent also details the selection of various cell surface markers useful for the in vitro generation of RPE cells.
Career Highlights
Lanner is associated with Biolamina AB, a company that focuses on developing and providing high-quality laminins for cell culture. His innovative methods contribute to the advancement of stem cell technology and its applications in medical treatments.
Collaborations
Lanner has collaborated with notable colleagues such as Álvaro Plaza Reyes and Sandra Petrus Reurer. Their combined expertise enhances the research and development efforts in the field of stem cell applications.
Conclusion
Karl Anders Fredrik Lanner's contributions to the field of stem cell research, particularly through his patented methods for producing RPE cells, highlight his role as an influential inventor. His work continues to pave the way for advancements in regenerative medicine and cell therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile